A rating of 73 puts Aeglea Bio Therapeutics Inc (AGLE) near the top of the Healthcare sector according to InvestorsObserver.
Aeglea Bio Therapeutics Inc’s score of 73 means that it ranks higher than 73% of stocks in the sector. In addition, its overall score of 28 ranks it higher than 28% of all stocks.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 28 would rank higher than 28 percent of all stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease.
These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What’s Happening With Aeglea Bio Therapeutics Inc Stock Today?
Aeglea Bio Therapeutics Inc (AGLE) stock has fallen -1.64% while the S&P 500 has gained 0.47% as of 2:41 PM on Wednesday, Nov 23. AGLE is lower by -$0.02 from the previous closing price of $1.22 on volume of 73,148 shares. Over the past year the S&P 500 has fallen -14.25% while AGLE is lower by -81.71%. AGLE lost -$1.15 per share the over the last 12 months.
Click Here to get the full Stock Report for Aeglea Bio Therapeutics Inc stock.
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Read More: Can Aeglea Bio Therapeutics Inc (AGLE) Stock Rise to the Top of Healthcare Sector